Meeting
2023 ASCO Gastrointestinal Cancers Symposium
Influence of clinical and tumor characteristics on survival in patients with hepatocellular carcinoma with bone metastasis.
Authors
Muhammet Ozer
Dana-Farber Cancer Institute, Boston, MA;
Muhammet Ozer , Suleyman Yasin Goksu , Jesus C. Fabregas , Brian Hemendra Ramnaraign , Sherise C. Rogers , Thomas J. George , Ilyas Sahin
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer
Sub Track
Patient-Reported Outcomes and Real-World Evidence
Citation
J Clin Oncol 41, 2023 (suppl 4; abstr 525)
DOI
10.1200/JCO.2023.41.4_suppl.525
Abstract #
525
Poster Bd #
B15
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Gastrointestinal Cancers Symposium
A decade of chemotherapy management in hepatocellular carcinoma: A single-center study in Latin America.
First Author: Wagner Eduardo Cruz Diaz
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Real-world analysis of irinotecan (iri) with or without fluorouracil (5FU) in the second line treatment (2L) of metastatic colorectal cancer (mCRC).
First Author: Robert William Lentz
Poster
2023 ASCO Annual Meeting
Efficacy and safety of HepaSphere drug-eluting bead transarterial chemoembolization combined with hepatic arterial infusion chemotherapy in advanced hepatocellular carcinoma.
First Author: Baojiang Liu
Poster
2023 ASCO Annual Meeting
Survival outcomes of sarcomatoid versus classic urothelial carcinoma of bladder.
First Author: Rohan Garje